
SpotitEarly is revolutionizing cancer pre-screening with an innovative AI-based test that can detect multiple cancer types from a single breath sample. This simple solution allows for easy, at-home sample collection in minutes, without any healthcare professional assistance. Their off-the-shelf test is affordable and available everywhere, at everyone’s convenience, removing barriers to timely testing. With an impressive 94% accuracy (sensitivity and specificity) in early-stage cancer detection, SpotitEarly harnesses the science of scent to identify cancerous VOCs in exhaled breath. This smart technology enables more frequent testing of wider audiences at a fraction of the cost, aiming to save lives and improve clinical outcomes globally.

SpotitEarly is revolutionizing cancer pre-screening with an innovative AI-based test that can detect multiple cancer types from a single breath sample. This simple solution allows for easy, at-home sample collection in minutes, without any healthcare professional assistance. Their off-the-shelf test is affordable and available everywhere, at everyone’s convenience, removing barriers to timely testing. With an impressive 94% accuracy (sensitivity and specificity) in early-stage cancer detection, SpotitEarly harnesses the science of scent to identify cancerous VOCs in exhaled breath. This smart technology enables more frequent testing of wider audiences at a fraction of the cost, aiming to save lives and improve clinical outcomes globally.